StockWatch
·
Pharmaceuticals
ESG9 Oct 2026, 11:41 am

Amrutanjan Health Care gets "Adequate" ESG rating from CRISIL

AI Summary

Amrutanjan Health Care Ltd has received an ESG rating of "Adequate" with a score of 60 from CRISIL ESG Ratings & Analytics Limited. Notably, the company did not engage CRISIL for this rating; it was an independent assessment based on publicly available information and disclosures. This rating indicates CRISIL's evaluation of the company's performance on environmental, social, and governance parameters.

Key Highlights

  • CRISIL independently rated Amrutanjan Health Care on ESG standards.
  • The company received an "Adequate" ESG rating with a score of 60.
  • The rating was based on public disclosures and available information.
  • Amrutanjan Health Care did not engage CRISIL for this assessment.